CURRENT MEDICAL DIAGNOSIS AND
TREATMENT 2026
65TH EDITION
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANKS
1)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Stem
A 52-year-old woman with well-controlled type 2 diabetes (A1c
6.8%) and no prior colorectal neoplasia presents for routine
health maintenance. She is asymptomatic. Which screening
strategy is most appropriate now?
A. Colonoscopy every 10 years starting now.
B. Fecal immunochemical testing (FIT) annually.
,C. CT colonography every 5 years.
D. Defer screening until age 60 because of diabetes.
Correct answer: A
Rationale — Correct (A)
For average-risk adults starting at age 45, colonoscopy every 10
years is a guideline-concordant, high-sensitivity screening
option. In a patient aged 52 with diabetes (not a reason to
delay), colonoscopy provides definitive visualization and
polypectomy if needed and aligns with CMDT recommendations
for age-based screening.
Rationales — Incorrect
B. FIT annually is an acceptable alternative for colorectal
screening but is not superior to colonoscopy in a 52-year-old
choosing definitive evaluation.
C. CT colonography is an alternative when colonoscopy is
contraindicated; it is not routinely preferred over colonoscopy
for initial screening.
D. Diabetes is not an indication to defer colorectal screening;
age-based screening should proceed.
Teaching point:
Begin colorectal cancer screening at age 45 for average-risk
adults; choose a validated screening modality.
Citation (APA):
Papadakis, M. A., McPhee, S. J., & Rabow, M. W. (2026). Current
Medical Diagnosis & Treatment (65th ed.). Ch. 1.
,2)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Stem
A 67-year-old man with 40 pack-year smoking history quit 12
years ago. He asks whether lung-cancer screening is needed. His
last chest radiograph 3 years ago was normal. Which is the best
next step?
A. Low-dose CT scan of the chest now.
B. Annual chest radiograph for surveillance.
C. No screening — quit time >10 years excludes eligibility.
D. Serum tumor marker (CEA) testing.
Correct answer: A
Rationale — Correct (A)
Current screening criteria include older adults with significant
smoking histories even if they quit within a defined interval;
low-dose CT (LDCT) is the evidence-based screening test that
reduces lung-cancer mortality and is preferred over chest
radiograph or tumor markers. In a 40 pack-year former smoker
with recent quit (≤15 years), LDCT is indicated.
Rationales — Incorrect
B. Chest radiograph does not reduce lung-cancer mortality and
is not recommended for screening.
C. Quit >10 years does not universally exclude screening if
, patient meets other criteria; shared decision and LDCT still
apply per recommendations.
D. Serum CEA is not a screening tool for lung cancer in
asymptomatic individuals.
Teaching point:
Use low-dose CT for eligible high-risk smokers/former smokers;
chest X-ray and serum markers are not screening tools.
Citation (APA):
Papadakis, M. A., McPhee, S. J., & Rabow, M. W. (2026). Current
Medical Diagnosis & Treatment (65th ed.). Ch. 1.
3)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Stem
A 28-year-old woman requests HPV vaccination. She reports no
prior HPV shots and is sexually active. Which statement best
guides your counseling and management?
A. Vaccination is not useful after age 26.
B. Shared decision-making is indicated for vaccination up to age
45.
C. Only high-risk women need HPV vaccination after age 21.
D. Pap testing should be replaced by HPV vaccination.
Correct answer: B
TREATMENT 2026
65TH EDITION
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANKS
1)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Stem
A 52-year-old woman with well-controlled type 2 diabetes (A1c
6.8%) and no prior colorectal neoplasia presents for routine
health maintenance. She is asymptomatic. Which screening
strategy is most appropriate now?
A. Colonoscopy every 10 years starting now.
B. Fecal immunochemical testing (FIT) annually.
,C. CT colonography every 5 years.
D. Defer screening until age 60 because of diabetes.
Correct answer: A
Rationale — Correct (A)
For average-risk adults starting at age 45, colonoscopy every 10
years is a guideline-concordant, high-sensitivity screening
option. In a patient aged 52 with diabetes (not a reason to
delay), colonoscopy provides definitive visualization and
polypectomy if needed and aligns with CMDT recommendations
for age-based screening.
Rationales — Incorrect
B. FIT annually is an acceptable alternative for colorectal
screening but is not superior to colonoscopy in a 52-year-old
choosing definitive evaluation.
C. CT colonography is an alternative when colonoscopy is
contraindicated; it is not routinely preferred over colonoscopy
for initial screening.
D. Diabetes is not an indication to defer colorectal screening;
age-based screening should proceed.
Teaching point:
Begin colorectal cancer screening at age 45 for average-risk
adults; choose a validated screening modality.
Citation (APA):
Papadakis, M. A., McPhee, S. J., & Rabow, M. W. (2026). Current
Medical Diagnosis & Treatment (65th ed.). Ch. 1.
,2)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Stem
A 67-year-old man with 40 pack-year smoking history quit 12
years ago. He asks whether lung-cancer screening is needed. His
last chest radiograph 3 years ago was normal. Which is the best
next step?
A. Low-dose CT scan of the chest now.
B. Annual chest radiograph for surveillance.
C. No screening — quit time >10 years excludes eligibility.
D. Serum tumor marker (CEA) testing.
Correct answer: A
Rationale — Correct (A)
Current screening criteria include older adults with significant
smoking histories even if they quit within a defined interval;
low-dose CT (LDCT) is the evidence-based screening test that
reduces lung-cancer mortality and is preferred over chest
radiograph or tumor markers. In a 40 pack-year former smoker
with recent quit (≤15 years), LDCT is indicated.
Rationales — Incorrect
B. Chest radiograph does not reduce lung-cancer mortality and
is not recommended for screening.
C. Quit >10 years does not universally exclude screening if
, patient meets other criteria; shared decision and LDCT still
apply per recommendations.
D. Serum CEA is not a screening tool for lung cancer in
asymptomatic individuals.
Teaching point:
Use low-dose CT for eligible high-risk smokers/former smokers;
chest X-ray and serum markers are not screening tools.
Citation (APA):
Papadakis, M. A., McPhee, S. J., & Rabow, M. W. (2026). Current
Medical Diagnosis & Treatment (65th ed.). Ch. 1.
3)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Stem
A 28-year-old woman requests HPV vaccination. She reports no
prior HPV shots and is sexually active. Which statement best
guides your counseling and management?
A. Vaccination is not useful after age 26.
B. Shared decision-making is indicated for vaccination up to age
45.
C. Only high-risk women need HPV vaccination after age 21.
D. Pap testing should be replaced by HPV vaccination.
Correct answer: B
